Answers are grounded in this paper and cite their sources.
Neoplastic growths seem to interfere with normal processes regulating the serum level of ceruloplasmin, a copper-containing oxidase, which accounts for 96% of serum copper. Normal catabolism of ceruloplasmin in the liver follows desialylation. However, in patients with tumors, ceruloplasmin may be resialylated at the tumor cell surface or in peripheral blood. Decreased catabolism due to resialylation of asialo-ceruloplasmin could account for the increased concentration of serum copper noted in patients with neoplasia.
No takes yet. Share an insight, caveat, or question.
Fisher et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: